Showing results (431-440 of 733) with videos related to
Sort By:
Pageof 74
Cancer Discovery|May 25, 2015
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapyNirupa Murugaesu, Gareth A Wilson, Nicolai J Birkbak, et al.Genome Biology|September 17, 2016
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancerNnennaya Kanu, Maria Antonietta Cerone, Gerald Goh, et al.Frontiers in Oncology|June 21, 2023
Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancerDavid R Pearce, Ayse U Akarca, Roel P H De Maeyer, et al.Nature Genetics|March 7, 2020
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolutionSaioa López, Emilia L Lim, Stuart Horswell, et al.Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.Nature Communications|April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axisCristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid TumorsChristopher J Sweeney, John D Hainsworth, Ron Bose, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced MelanomaJeffrey S Weber, F Stephen Hodi, Jedd D Wolchok, et al.British Journal of Cancer|August 17, 2019
Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIMKarl D Lewis, James Larkin, Antoni Ribas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2022
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 TrialBrian I Rini, Javid J Moslehi, Marc Bonaca, et al.Pageof 74